Markets · 1 sources covering this

Augmont Enterprises IPO Day 2: GMP jumps to 48%, issue subscribed 2.74x — Should you subscribe?

Augmont Enterprises IPO entered its second day with strong demand, reaching 2.74 times subscription on Day 1. GMP climbed to 48%, indicating potential listing gains. The Rs 825 crore issue benefits from an integrated gold and silver ecosystem, strong financial growth and positive brokerage views, though valuation and working-capital risks remain.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·3h ago
Augmont Enterprises IPO Day 2: GMP jumps to 48%, issue subscribed 2.74x — Should you subscribe?
Augmont Enterprises IPO entered its second day with strong demand, reaching 2.74 times subscription on Day 1. GMP climbed to 48%, indicating potential listing gains. The Rs 825 crore issue benefits from an integrated gold and silver ecosystem, strong financial growth and positive brokerage views, though valuation and working-capital risks remain.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/d86919bfb8ad52815c2c3fbc1a3ed59ab6b5889c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Augmont Enterprises IPO Day 2: GMP jumps to 48%, issue subscribed 2.74x — Should you subscribe?"></iframe>

Augmont Enterprises IPO Day 2: GMP jumps to 48%, issue subscribed 2.74x — Should you subscribe?

How 1 sources are covering this

Augmont Enterprises IPO Day 2: GMP jumps to 48%, issue subscribed 2.74x — Should you subscribe?

More from Markets

Small-cap IT stock under ₹50 jumps 5% after implementation of SpaceX International agreement plan

Avaada said to plan public filing for $800 million IPO

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

Madhur Knit Crafts, ABH Healthcare SME IPOs Day 1: Early subscription, GMP, and key details

Reader

Trust & legal

Across the network